Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 19, 2002, 10.1148/radiol.2243010909
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2243010909v1
224/3/713    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thornton, F. J.
Right arrow Articles by Lee, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thornton, F. J.
Right arrow Articles by Lee, M. J.
(Radiology 2002;224:713-717.)
© RSNA, 2002


Vascular and Interventional Radiology

Amyotrophic Lateral Sclerosis: Enteral Nutrition Provision—Endoscopic or Radiologic Gastrostomy?1

Frank J. Thornton, MD, Timothy Fotheringham, MD, Michael Alexander, MD, Orla Hardiman, MD, Frank P. McGrath, MD and Michael J. Lee, MD

1 From the Departments of Interventional Radiology (F.J.T., T.F., F.P.M., M.J.L.) and Neurology (M.A., O.H.), Beaumont Hospital, PO Box 1297, Beaumont Rd, Dublin 9, Ireland. Received May 11, 2001; revision requested July 9; final revision received February 14, 2002; accepted March 1. Address correspondence to M.J.L. (e-mail: leebeau@iol.ie).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PURPOSE: To retrospectively evaluate gastrostomy placement in patients with amyotrophic lateral sclerosis (ALS) to determine the insertion method of choice.

MATERIALS AND METHODS: During 31/2 years, 36 patients with ALS (19 men, 17 women; mean age, 54 years; age range, 37–69 years) underwent gastrostomy. Twenty patients were primarily referred for percutaneous endoscopic gastrostomy (PEG) and 16 for percutaneous radiologic gastrostomy (PRG). Gastrostomy method, success rate of each technique, and reason for procedure failure were reviewed in each patient. Forced vital capacity (FVC) prior to gastrostomy was recorded. PEG was performed with a pull-through technique after transillumination of the abdominal wall. PRG was performed with fluoroscopic guidance and T-fastener gastropexy. A log-rank test was used to compare survival rates after PRG and PEG, and a Wilcoxon rank sum test was used to evaluate the influence of declining FVC on PEG success. The Kaplan-Meier product limit method was used to estimate survival probabilities.

RESULTS: Of the 20 patients referred for PEG, 11 had successful results. The nine failures (45%) resulted from failure to transilluminate the abdominal wall. All 16 patients primarily referred for PRG underwent successful gastrostomy. The nine patients in whom PEG failed underwent subsequent successful PRG. In patients with diaphragmatic palsy and a high subcostal stomach, an angled subcostal approach (n = 6) or intercostal approach (n = 2) was required at PRG. One death occurred in the PEG group (9%) because of procedure-related aspiration, and a second patient from the PEG group required laparotomy for postprocedural peritonitis. One death occurred in the PRG group (4%) because of inadvertent placement of the feeding tube in the peritoneal cavity. There was no significant difference between PEG and PRG in patient survival. FVC did not have a statistically significant influence on PEG failure.

CONCLUSION: Results show PRG to be the method of choice.

© RSNA, 2002

Index terms: Amyotrophic lateral sclerosis, 72.613 • Gastrostomy, 72.1267 • Stomach, interventional procedures, 72.1267 • Stomach, surgery, 72.1267


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Amyotrophic lateral sclerosis (ALS) is a fatal degenerative neurologic disease caused by pathologic and progressive loss of anterior horn cells of the spinal cord and the motor nuclei of the brainstem and corticospinal tracts (13). Dysphagia is a common feature of the bulbar form of ALS and puts the patient at risk for suboptimal caloric and fluid intake (4,5). Initial management of dysphagia involves modification of food consistency and advice regarding safe swallowing. As the disease progresses, however, the necessity for an alternative route of enteral nutrition grows (6). Since the option of gastrostomy feeding exists, it is now considered a standard of care for patients who have ALS and relative preservation of respiratory function (79).

The bulbar, cervical, and thoracic loss of motor neurons associated with ALS predisposes patients to aspiration pneumonia, which aggravates respiratory failure and often accelerates the natural course of the disease (10,11). Management of respiratory failure involves strategies that limit aspiration, reduce secretions, and position the patient to a maximal mechanical advantage (6).

Both percutaneous endoscopic gastrostomy (PEG) and percutaneous radiologic gastrostomy (PRG) techniques have been used successfully in patients with ALS, although to our knowledge, there have been no formal clinical trials reported in the literature (12). Wollman and D'Agostino (13) noted that migration of the stomach into the thoracic cavity because of diaphragmatic weakness may preclude transillumination of the anterior abdominal wall at endoscopy and make safe gastrostomy impossible. PRG with fluoroscopic guidance and other inherent safety factors has an intrinsic versatility that surmounts this problem (14).

A comparison of both procedures when applied to the management of ALS has not been reported in the literature, to our knowledge. Thus, we retrospectively evaluated both PEG and PRG methods of gastrostomy placement in patients with ALS at our institution to determine the insertion method of choice.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Data were analyzed retrospectively in patients who had ALS and were referred for gastrostomy feeding-tube insertion between July 1997 and March 2001. Currently, institutional review board approval or consent is not required at our institution for such a retrospective study. Thirty-six patients (19 men, 17 women; mean age, 54 years; age range, 37–69 years) with ALS were referred. Twenty of 36 were primarily referred for PEG and 16 for PRG. Referral for gastrostomy was based on the following criteria: weight loss of more than 10%, declining forced vital capacity (FVC), and evidence of aspiration. Between July 1997 and July 1999, all patients were initially referred for PEG. After this, the neurology service selected patients for primary PEG or PRG on the basis of the following clinical criteria:

1. Patients who had moderate debilitation, bulbar symptoms, high risk of perioperative aspiration, more than 10% body weight loss, and FVC of 40%–60% were referred for PRG.

2. Patients who were less than 50 years old with more than 10% body weight loss and FVC of more than 50% and who were otherwise well with only mild bulbar symptoms and a low aspiration risk were referred for PEG. Those in whom PEG was unsuccessful were referred for PRG.

3. Patients who have FVC of more than 75% who are otherwise well, without bulbar symptoms or weight loss, are not currently offered gastrostomy.

4. Patients who have FVC of less than 40% are not routinely offered gastrostomy, since current evidence suggests that the procedure does not confer survival benefit in this population.

The criteria as outlined have since been revised, and since July 2001, all those requiring gastrostomy are referred directly for PRG. Evidence-based referral criteria have not yet been described in the literature, to our knowledge, although guidelines have been published (15). Informed consent was obtained from all patients.

PEG was performed by using a modification of the Gauderer-Ponsky pull-through method described in 1980 (16). The procedure was performed in the endoscopy unit by two endoscopists experienced in this technique, with the patient consciously sedated with 4 mg of midazolam (Rocke, Basel, Switzerland) and 50 mg of pethidine hydrochloride (Antigen Pharmaceuticals, Roscrea, Ireland). The gastroscope was passed into the patient’s stomach, and the gastroscope light source was used to transilluminate the anterior abdominal wall to select a suitable gastrostomy site. Local anesthesia was administered, and a small incision was made before puncturing the anterior wall of the stomach with a Seldinger needle. A guide wire was fed through the needle and snared through the gastroscope. The gastroscope was slowly removed, bringing the wire out through the patient’s mouth. The PEG tube was attached to the guide wire, and the abdominal end was pulled gently but firmly so that the tube passed through the mouth and esophagus and into the stomach. The proximal end of the 16-F feeding tube (Flexiflo Dura-PEG; Abbott, Sligo, Ireland) was pulled through the abdominal wall until the retaining flange juxtaposed the anterior stomach wall and the anterior abdominal wall. A fixation clip was attached externally to complete the procedure.

PRG was performed with fluoroscopic guidance, as previously described by using the Seldinger technique (14). Patients received 300 mL of dilute barium (E-Z-EM, Westbury, NY) either orally or by means of a nasogastric tube the night before the procedure to opacify the transverse colon, and a nasogastric tube was inserted, through which the stomach was insufflated with air during the procedure. All procedures were performed by one of three interventional radiologists (T.F., M.J.L., F.P.M.) experienced in the gastrostomy procedure, with the patient consciously sedated with 2 mg of midazolam and 100 µg of fentanyl citrate (Antigen Pharmaceuticals). Local anesthesia was administered before all cutaneous punctures.

Gastropexy with T-fasteners (Boston Scientific, Natick, Mass) was the primary step performed in all procedures. Gastropexy fixes the anterior wall of the stomach to the anterior abdominal wall, which stabilizes the anterior wall of the stomach and allows safe dilation of the gastrostomy tract (14,17). This step was achieved by using four T-fasteners inserted into the gastric antrum at the corners of a 2-cm square around the site of the proposed gastrostomy. It was not possible to establish gastropexy with four T-fasteners in six patients because of limited access to the anterior abdominal wall. At least two T-fasteners were used in all patients.

An 18-gauge needle was used to puncture the center point of the square-configured gastropexy, and a 0.038-inch Amplatz Super Stiff guide wire (Boston Scientific, Galway, Ireland) was coiled in the stomach. This tract was dilated as much as 16 F by using increasing dilator sizes passed over the guide wire. It was standard practice to screen patients between each successive dilation of the gastrostomy tract to check guide wire position and to ensure optimum stomach inflation with air. Finally, a gastrostomy feeding tube was inserted over the guide wire, and a test injection of 10–20 mL of contrast medium (Iohexol 300 or Omnipaque 300; Nycomed, Oslo, Norway) through the gastrostomy tube was performed to check gastrostomy tube position.

A 14-F gastrostomy tube (Cook, Bloomington, Ind) was used in 20 of 25 patients (16 primary PRG referrals and nine failed PEG cases). A 14-F button gastrostomy (MIC-KEY G Low Profile Gastrostomy Kit; Medical Innovation, Draper, Utah) was used in the last five patients (18), with one of these being an elective replacement of the standard, previously used gastrostomy tube.

Technical difficulties encountered, as well as success rate of placement, in both PEG and PRG were obtained from patient records, which were reviewed by two authors (F.J.T., M.A.). Immediate postprocedural complications were recorded. FVC prior to gastrostomy was documented. Follow-up continued in conjunction with the clinical team until the time this article was written, and the survival period was noted from the day of gastrostomy.

Statistical calculations were made to assess the effect of declining FVC on PEG performance and the ability to transilluminate the anterior abdominal wall. The nonparametric Wilcoxon rank sum test was used to determine any difference in FVC levels between groups. Survival time in both the PEG and PRG groups was also analyzed. Statistical results were defined as significant for a P value of .05 or less. The log-rank test for the equality of survivor functions among groups was used, and Kaplan-Meier product limit estimates to determine the survival probabilities at different intervals were implemented.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
PEG had a 53% (11 of 20) success rate in this patient series. PRG had a 100% success rate of placement, both for primary referrals and for failed PEG referrals (Table).


View this table:
[in this window]
[in a new window]

 
Differences between PEG and PRG Results in Patients with ALS

 
Failure to optimally transilluminate the anterior abdominal wall was the cause of PEG failure in all nine (45%) of 20 patients. This failure was compounded by obesity in one patient. Fluoroscopic results in many of these patients showed the stomach lying high, under the lower left rib cage. Choosing the site for gastrostomy tube placement in all these patients proved a challenge, since the antrum and greater curve lay directly beneath the left costal margin.

In two patients referred for PRG after failed PEG, the stomach was not visible below the costal margin at fluoroscopy after distention with air because of diaphragmatic palsy. Intercostal gastrostomy tube placement was required in these two patients. The lowest intercostal space was chosen in both. Chest fluoroscopy performed in these patients at the end of each procedure did not show pneumothorax. In six patients (four patients with failed PEG and two primary PRG referrals), a small portion of the stomach descended below the costal margin after air insufflation; by using a steep cephalic track angulation, it was possible to place a gastrostomy tube. Gastropexy in these cases was also difficult because of diaphragmatic palsy, with space for only two T-fasteners instead of the usual four in these six patients.

One patient who had previously undergone attempted PEG provided a substantial technical challenge. The reason for PEG failure in this patient related to obesity and a high-lying stomach. These factors prevented transillumination of the anterior abdominal wall. At PRG, the air-distended stomach was visualized, but it was not possible to safely dilate the tract to the required 14-F size. A 10-F pigtail catheter (Boston Scientific, Galway, Ireland) was temporarily placed, and the patient was electively recalled for optimal dilation of the tract and placement of a 14-F gastrostomy tube.

One patient who underwent successful primary PEG aspirated pharyngeal secretions into the larynx during endoscopy and died during respiratory arrest 24 hours after the procedure. This patient had asthma and FVC of 17%. No aspiration events were recorded in the PRG patient group. A second patient in the PEG group, who developed acute abdomen within 24 hours after the procedure, required explorative laparotomy. A leak was discovered around the gastrostomy site on the anterior wall of the stomach and was repaired.

There was one procedure-related complication in the PRG group. This patient underwent a failed PEG attempt 2 days prior to PRG and, during the PRG procedure, had inadvertent placement of the gastrostomy tube in the peritoneal cavity. A test injection of contrast medium (Iohexol 300 or Omnipaque 300; Nycomed) was performed, as is standard, but results were misinterpreted, and the tube malposition was not detected. The patient was subsequently fed through the tube and developed peritonitis. Despite emergency laparotomy, the patient died 4 days after the procedure.

The mean FVC was 53% (range, 35%–97%) in the successful primary PEG group and 57% (range, 12%–95%) in the subset of patients in whom primary PEG failed. In the patient group referred primarily for PRG, the mean FVC was 61% (range, 43%–100%). No significant difference in FVC was observed between the patients who underwent successful PEG and those in whom PEG failed (P = .52) or between those who underwent PRG and those in whom PEG failed (P = .125). Twenty-one patients of the 36 have died at the time of preparing this article. The estimated median survival time was 13 months (range, 0–16 months) from the date of gastrostomy. There was no significant difference detected in survival rates between the PEG and PRG groups (P = .165) (Figure).



View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Line graph of Kaplan-Meier product limit estimates to determine the survival probabilities (vertical axis) at different times.

 
Seventeen tube replacements were performed in 10 patients from the PRG group during a summated gastrostomy time of 107 months, for an average 6-month life span for gastrostomy tubes in these patients. Replacement was necessitated by inadvertent removal of the tube or gastrostomy tube balloon rupture by the patient or their caregiver. All but one of these replacements was performed through the original tract, with fluoroscopy and without conscious sedation. The tract in the remaining patient had closed because of delayed presentation and required de novo PRG. Only two gastrostomy replacements were required in the 11 patients from the PEG group.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Gastrostomy feeding is a well-tolerated and efficient method of providing enteral nutrition in an ill patient population (19). It facilitates nursing care in either a hospital or home environment because of the simplicity of enteral feeding and the minimal disturbance it causes the patient (20). The method used for such alimentation must have minimal stress, morbidity, and likelihood of death for the patient and acceptable long-term success; and in the current environment of fiscal accountability, it must be of reasonable cost to the health care system. Both PRG and PEG have been shown to fit all of the listed criteria (21).

There is an intrinsic risk of aspiration in patients with ALS because of dysfunction of the swallowing mechanism (22). Results of a meta-analysis of the literature by Wollmann et al (23) showed a significantly greater risk of aspiration associated with PEG, as compared with the risk associated with PRG (2.1% vs 0.6%; P < .001). Performance of PEG in patients with ALS will theoretically further increase the risk of aspiration during or immediately after the procedure. This proposed risk relates to the degree of conscious sedation required for PEG, the degree of pharyngeal anesthesia required, and the mechanical stress imposed during endoscopy in an already compromised swallowing and antireflux mechanism. In our study, one patient from the PEG group aspirated, which resulted in death. In the PRG group, there were no aspiration events recorded.

Safe performance of PEG depends on adequate transillumination of the anterior abdominal wall by the gastroscope light. In some patients with ALS, because of intrinsic weakness of the diaphragm, the stomach migrates high under the costal margin. Such anomalous anatomy, especially when compounded by obesity, precludes transillumination of the abdominal wall at a safe access site. Furthermore, there is a greater risk of penetrating a vital thoracic structure if the gastroscope light is the only guiding factor. Further navigational information is essential before safely proceeding to gastrostomy placement in such patients. This information is readily available when the PRG protocol is applied. Anteroposterior and lateral fluoroscopy while the stomach is insufflated with air and the colon opacified with barium provides an accurate real-time road map to plan the gastrostomy.

Use of an intercostal route or angled subcostal route for gastrostomy placement has been described (12). When necessary, we use the lowest anterior intercostal space, where the pleural reflection is less likely to be traversed. We have experienced no additional morbidity with this approach.

The 53% success rate of PEG in our institution is much lower than the 89% success rate in reported in another article (24). This discrepancy may be partly related to different selection criteria for patients who have ALS and undergo PEG. In the population of patients with ALS in our study, six of 20 referred for PEG had FVC of less than 50%. Evidence-based reviews by Miller (25) and Bradley et al (26) describe FVC of 30%–50% as moderate risk and FVC of less than 30% as high risk for performing PEG. These data have not been validated for PRG. It is of interest that in the patients with ALS in our study, there was no correlation between FVC and failure of the PEG technique (ie, raised diaphragmatic level). It is uncertain whether this relates to compensatory activity by accessory muscles of respiration, developing better in some patients than others, or some other factor. Formal clinical trials will be required to answer this question.

A further factor that favors PRG over PEG in patients with ALS is the degree of conscious sedation required (13). Less sedation is necessary for PRG, with less associated chance of respiratory suppression, which is already compromised in patients with ALS (10). In our institution, 2 mg of midazolam is administered prior to PRG, as compared with 4 mg administered for PEG. Furthermore, local anesthesia of the pharyngeal mucosa is not necessary in PRG, which eliminates another risk factor for aspiration.

T-fastener gastropexy enables routine use of larger gastrostomy tubes and ready replacement of a displaced tube even before the development of a mature tract (17). The inability to perform standard gastropexy with four T-fasteners in some patients with ALS is a potential hazard when performing PRG. The problem relates to difficulty in dilating the gastrostomy tract without gastropexy when the anterior stomach wall is pushed away by the dilator. There is a real risk of inadvertent placement of the tube in the peritoneal cavity in these patients. Where suboptimal gastropexy is achieved, additional care must be taken with fluoroscopy during dilation of the gastrostomy tract.

The incidence of tube replacement after PRG is greater than that seen in the PEG group. We believe this incidence results from the difference in retaining mechanisms of gastrostomy tubes designed for PRG and those designed for PEG. In our experience, the balloon-retaining device used in all the patients undergoing PRG in our study is less effective than the flange mechanism used in PEG tubes. The recommended 5-mL exchange of water at 2-week intervals in PRG balloons frequently results in overdistention and rupture. Some of the balloons ruptured spontaneously (27). The remaining tubes were inadvertently pulled out. The flange system used in the PEG feeding tubes has less potential to become displaced, which results in a lower need for PEG replacement, as seen in the PEG group in our study.

The death related to PEG resulted from aspiration of a pharyngeal mucous plug during passage of the gastroscope. This complication is consistent with the underlying inability of patients with ALS to efficiently swallow their oral secretions. PRG averts the risk of aspiration in these patients.

The death related to PRG resulted from placement of the feeding tube in the peritoneal cavity despite the presence of a T-fastener gastropexy. This was not recognized at the time of the procedure, despite a test injection of contrast medium (Iohexol 300 or Omnipaque 300; Nycomed). This patient had previously undergone PEG that failed due to failure to transilluminate the anterior abdominal wall. The high stomach position in these patients presents a technical challenge, since the approach for gastrostomy placement is angled rather than perpendicular to the abdominal wall. This angling increases the risk of losing guide wire position while dilating the gastrostomy tract, which probably occurred in this case. The deaths experienced in both groups highlight the technical difficulties that ALS presents.

In conclusion, patients with ALS present a challenge to both endoscopists and interventional radiologists when gastrostomy is required. PRG had a significantly higher success rate than did PEG in the patients with ALS in our study. The requirement for less sedation for PRG and the avoidance of the endoscopic route of placement lower the intrinsic risk of aspiration and establish PRG as the preferred primary gastrostomy technique in patients with ALS.


    ACKNOWLEDGMENTS
 
We acknowledge the statistical help provided for this study by Patrick O'Kelly, BA, Beaumont Hospital, Dublin, Ireland.


    FOOTNOTES
 
Abbreviations: ALS = amyotrophic lateral sclerosis, FVC = forced vital capacity, PEG = percutaneous endoscopic gastrostomy, PRG = percutaneous radiologic gastrostomy

Author contributions: Guarantor of integrity of entire study, M.J.L.; study concepts, O.H., M.J.L.; study design, F.J.T., O.H., M.J.L.; literature research, F.J.T.; clinical studies, T.F., F.P.M., M.J.L.; data acquisition, T.F., F.P.M., F.J.T., M.A.; data analysis/interpretation, M.A., T.F., F.J.T.; statistical analysis, F.J.T.; manuscript preparation, M.A., F.J.T.; manuscript definition of intellectual content, M.J.L., F.P.M., O.H.; manuscript editing, M.J.L., O.H.; manuscript revision/review, F.P.M., M.J.L.; manuscript final version approval, M.J.L.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Milonas I. Amyotrophic lateral sclerosis: an introduction. J Neurol 1998; 245(suppl 2):S1-S3.
  2. Bromberg MB. Pathogenesis of amyotrophic lateral sclerosis: a critical review. Curr Opin Neurol 1999; 12:581-588.[CrossRef][Medline]
  3. Ince PG, Lowe J, Shaw PJ. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998; 24:104-117.[CrossRef][Medline]
  4. Desport JC, Preux PM, Truong TC, Vallat JM, Sautereau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology 1999; 53:1059-1063.[Abstract/Free Full Text]
  5. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998; 50:66-72.
  6. Hardiman O. Symptomatic treatment of respiratory and nutritional failure in amyotrophic lateral sclerosis. J Neurol 2000; 247:245-251.[CrossRef][Medline]
  7. Mazzini L, Corra T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995; 242:695-698.[CrossRef][Medline]
  8. Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 1999; 169:118-125.[CrossRef][Medline]
  9. Silani V, Kasarskis EJ, Yanagisawa N. Nutritional management in amyotrophic lateral sclerosis: a worldwide perspective. J Neurol 1998; 245(suppl 2):S13-S19.
  10. Gelanis DF. Respiratory failure or impairment in amyotrophic lateral sclerosis. Curr Treat Options Neurol 2001; 3:133-138.[Medline]
  11. Carter GT, Johnson ER, Bonekat HW, Lieberman JS. Laryngeal diversion in the treatment of intractable aspiration in motor neuron disease. Arch Phys Med Rehabil 1992; 73:680-682.[Medline]
  12. Thornton FJ, Varghese JC, Haslam PJ, McGrath FP, Keeling F, Lee MJ. Percutaneous gastrostomy in patients who fail or are unsuitable for endoscopic gastrostomy. Cardiovasc Intervent Radiol 2000; 23:279-284.[CrossRef][Medline]
  13. Wollman B, D’Agostino HB. Percutaneous radiologic and endoscopic gastrostomy: a 3-year institutional analysis of procedure performance. AJR Am J Roentgenol 1997; 169:1551-1553.[Abstract/Free Full Text]
  14. Ryan JM, Hahn PF, Boland GW, McDowell RK, Saini S, Mueller PR. Percutaneous gastrostomy with T-fastener gastropexy: results of 316 consecutive procedures. Radiology 1997; 203:496-500.[Abstract/Free Full Text]
  15. Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology—ALS Practice Parameters Task Force. Neurology 1999; 52:1311-1323.[Free Full Text]
  16. Gauderer MW, Ponsky JL, Izant RJ, Jr. Gastrostomy without laparotomy: a percutaneous endoscopic technique. J Pediatr Surg 1980; 15:872-875.[Medline]
  17. Thornton FJ, Fotheringham T, Haslam PJ, McGrath FP, Keeling F, Lee MJ. Percutaneous radiological gastrostomy with and without T-fastener gastropexy: a randomized comparison study. Cardiovasc Intervent Radiol; (in press).
  18. Ruangtrakool R, Ong TH. Primary gastrostomy button: a means of long-term enteral feeding in children. J Med Assoc Thai 2000; 83:151-159.[Medline]
  19. De Vivo P, Mastronardi P, Ciritella P, et al. Early percutaneous endoscopic gastrostomy (PEG): a safe and effective enteral feeding technique in neurologic intensive care unit. Minerva Anestesiol 1996; 62:197-201.[Medline]
  20. Norton B, Homer-Ward M, Donnelly MT, Long RG, Holmes GK. A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding after acute dysphagic stroke. BMJ 1996; 312:13-16.[Abstract/Free Full Text]
  21. Pender SM, Courtney MG, Rajan E, McAdam B, Fielding JF. Percutaneous endoscopic gastrostomy: results of an Irish single unit series. Ir J Med Sci 1993; 162:452-455.[Medline]
  22. Hadjikoutis S, Pickersgill TP, Dawson K, Wiles CM. Abnormal patterns of breathing during swallowing in neurological disorders. Brain 2000; 123:1863- 1873.[Abstract/Free Full Text]
  23. Wollman B, D’Agostino HB, Walus-Wigle JR, Easter DW, Beale A. Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature. Radiology 1995; 197:699-704.[Abstract/Free Full Text]
  24. Mathus-Vliegen LM, Louwerse LS, Merkus MP, Tytgat GN, Vianney de Jong JM. Percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and impaired pulmonary function. Gastrointest Endosc 1994; 40:463-469.[Medline]
  25. Miller RG. Examining the evidence about treatment in ALS/MND. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2:3-7.[CrossRef][Medline]
  26. Bradley WG, Anderson F, Bromberg M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology 2001; 57:500-504.
  27. Ruangtrakool R, Ong TH. Comparison between mushroom-type and balloon-type gastrostomy buttons. J Med Assoc Thai 2000; 83:719-724.[Medline]



This article has been cited by other articles:


Home page
BMJHome page
C. J McDermott and P. J Shaw
Diagnosis and management of motor neurone disease
BMJ, March 22, 2008; 336(7645): 658 - 662.
[Full Text] [PDF]


Home page
RadiologyHome page
A. S. Shaw, M. A. Ampong, A. Rio, J. McClure, P. N. Leigh, and P. S. Sidhu
Entristar Skin-Level Gastrostomy Tube: Primary Placement with Radiologic Guidance in Patients with Amyotrophic Lateral Sclerosis
Radiology, November 1, 2004; 233(2): 392 - 399.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A Chio, R Galletti, C Finocchiaro, D Righi, M A Ruffino, A Calvo, N Di Vito, P Ghiglione, A A Terreni, and R Mutani
Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS
J. Neurol. Neurosurg. Psychiatry, April 1, 2004; 75(4): 645 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P N Leigh, S Abrahams, A Al-Chalabi, M-A Ampong, L H Goldstein, J Johnson, R Lyall, J Moxham, N Mustfa, A Rio, et al.
The management of motor neurone disease
J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(90004): iv32 - 47.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
B J Traynor, M Alexander, B Corr, E Frost, and O Hardiman
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000
J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1258 - 1261.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2243010909v1
224/3/713    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thornton, F. J.
Right arrow Articles by Lee, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thornton, F. J.
Right arrow Articles by Lee, M. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE